side effects from taking glp 1 Press Release Page GLP-1 medications have changed the

The study, published Wednesday in The BMJ , a globally respected peer-reviewed British medical journal, followed patients for an average of 2.7 years and found that the increased risk was concentrated in non-scarring alopeciaa type of hair loss that does not permanently destroy the follicles

Book an appointment to discuss your available options

There were about 3.8 million GLP-1 prescriptions covered by Medicaid in 2023, compared to 755,000 in 2019, results show

Also, market share analysis and key trend analysis are the major success factors in the market report

This means there are virtually no peer-reviewed human studies showing that these patches cause weight loss